Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-20

FDA Approved: BUPRENORPHINE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s original application for generic buprenorphine, enabling its marketing in the United States for approved indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

ORIG AP for BUPRENORPHINE (BUPRENORPHINE)